LONDON/COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk is facing a major challenge to its blockbuster weight-loss drug Wegovy. Booming sales of Wegovy powered the company to become Europe's most ...
Novo Nordisk secured U. regulatory approval for its weight-loss pill, ​giving the Danish drugmaker a shot at reclaiming ground lost ‌to rival Eli Lilly.
By Maggie Fick, Jacob Gronholt-Pedersen and Bhanvi Satija LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback